Check category
Types of PEGylation of Protein Drugs

Types of PEGylation of Protein Drugs



According to the different nature of the reaction between chemical modifiers and proteins, the modification reactions are mainly divided into acylation reactions, alkylation reactions, redox reactions, aromatic ring substitution reactions, etc. group for chemical modification.


According to the different molecular weights, molecular structures and physicochemical properties of the modified compounds, including proteins, polypeptides, monoclonal antibody fragments, and small molecular compounds, the company adopts different PEGylation techniques to modify these compounds. Modification methods include:


1. Random modification

Randomly modified proteins mostly target ε-NH2 or α-NH2 of lysine. Since lysine is usually in large quantity in the protein, this modification causes multiple lysines in the protein to be modified, and the resulting product is The mixture of PEGylated isomers, most of the new PEGylated drugs approved by the FDA are currently randomly modified products.


2. Fixed-point modification

PEGylation site-directed modification is a second-generation polyethylene glycol modification technology developed on the basis of random modification. By optimizing the selection of modification methods, PEG modifiers and reaction pH, site-directed modification is realized. This modification The obtained product is a homogeneous product with less isomers, better activity retention and greatly reduced immunogenicity.


1) N-terminal amino group site-directed modification

Due to the existence of multiple α-NH2 and ε-NH2 groups in proteins and polypeptides, random modification of amino groups may lead to a significant decrease in drug activity, which brings obstacles to the modification of proteins and polypeptides. At present, we adopt the site-directed modification of the N-terminal amino group, especially for the N-terminal site-directed modification far from the active center, which can effectively maintain the original biological activity of the drug.


2) Thiol site-directed modification

Combined with genetic engineering technology or Mutagenesis and other methods, thiol groups or some specific groups are introduced into the preset sites of proteins and polypeptides (such as glycosylation sites that do not affect activity, antigenic determinants, etc.) In this way, site-directed modification products with higher activity retention and reduced immunogenicity can be obtained.


3) Carboxyl site-directed modification

Using polyethylene glycol derivatives with hydrazide activating groups to modify the carboxyl groups of proteins and polypeptides, a site-specific modification product can also be obtained.


4) Enzymatic modification

The third-generation PEGylation site-directed modification technology uses enzymatic catalysis to induce targeted modification of polyethylene glycol molecules and specific sites on proteins, polypeptides and other molecules. This method has the following characteristics: 1) no structural modification of the original protein and polypeptide is required, and the physicochemical properties of the original compound remain unchanged; 2) fixed-point modification; 3) the process is simple, and it is easy to large-scale production and quality control.


ADD:No.999, Jiangyue Road, Pujiang Town,
Minhang District, Shanghai, China

TEL:+86 13671558889